Drugs Made In America Acquisition Stock Price History
NASDAQ: DMAAFinancial ServicesShell CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DMAA price history at a glance
The price history for Drugs Made In America Acquisition (DMAA) on this page begins on October 7, 2026, when the stock closed at $10.84; it most recently closed at $10.85 on October 9, 2026. The highest price in this record is $10.85, reached on October 8, 2026, and the stock is trading near that level today. Prices are split-adjusted closing prices; daily open, high, low, close and volume for the past year are listed below.
Summary generated from market data by MetaCap's automated system. Methodology
Key price levels
- High since 2026
- $10.85
- Date of high
- Oct 8, 2026
- Low since 2026
- $10.82
- Date of low
- Oct 7, 2026
- 52-week high
- $10.89
- 52-week low
- $10.28
- IPO year
- 2025
- Last close
- $10.85
DMAA returns
1 week
+0.09%
DMAA price return, excluding dividends.
DMAA daily prices (past year)
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| 10.85 | 10.85 | 10.85 | 10.85 | 0.00% | |
| 10.85 | 10.85 | 10.85 | 10.85 | +0.09% | |
| 10.82 | 10.84 | 10.82 | 10.84 | — |
Prices are adjusted for stock splits. See adjusted closing price for how dividends and splits affect history, and the DMAA chart for longer ranges.